Grape King Bio Ltd

1707

TW0001707008

Food Processing

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
158 ^TWD	+0.64%		+2.27%	+1.28%

Feb. 27	Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 09	Grape King Bio Hits Record-High Sales of NT$10.64 Billion in 2023	MT

Grape King Bio Ltd Announces Cash Dividends, Payable on from Sept. 2, 2021

July 15, 2021 at 02:40 am EDT

Grape King Bio Ltd. announced cash dividends to shareholders of TWD 6.4 per share total amount of cash distributed to shareholders of TWD 948,079,187. The dividend distribution starts from Sept. 2, 2021. Ex-rights (ex-dividend) record date of Aug. 08, 2021. Ex-rights (ex-dividend) trading date of Aug. 03, 2021.

Latest news about Grape King Bio Ltd

Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Grape King Bio Hits Record-High Sales of NT$10.64 Billion in 2023	Jan. 09	MT
Grape King Bio Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
Grape King Bio Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Grape King Bio Ltd Announces Cash Dividend, Payable on July 21, 2023	23-05-31	CI
Grape King Bio Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Grape King Bio Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Grape King Bio Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08	CI
Grape King Bio Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Grape King Bio Ltd Announces Cash Dividend	22-05-27	CI
Grape King Bio Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Grape King Bio Ltd Applies to FDA for A Phase II Clinical Trial Review in Humans for GKAC	22-02-11	CI
Grape King Bio Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-04	CI
Grape King Bio : Sales Soar 6% in September	21-10-14	MT
Grape King Bio Ltd Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-03	CI
Grape King Bio Ltd to Appoint the Remuneration Committee Member	21-08-02	CI
Grape King Bio Ltd Announces Establishment of the Audit Committee	21-07-15	CI
Grape King Bio Ltd Announces Cash Dividends, Payable on from Sept. 2, 2021	21-07-15	CI
Grape King Bio Ltd Announces Board Changes	21-07-15	CI
Grape King Bio Ltd Announces Board Changes	21-07-15	CI
Grape King Bio Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-05	CI
Grape King Bio Ltd announced that it has received TWD 2.01467 billion in funding from Uni-President Enterprises Corp.	21-03-04	CI
Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI

Chart Grape King Bio Ltd

Duration

Period

More charts

Company Profile

Grape King Bio Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of healthcare products and beverages. The company operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The Company operates in Taiwan, mainland China and other markets.

Sector

Food Processing

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Grape King Bio Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

158 TWD

Average target price

172.8 TWD

Spread / Average Target

+9.34%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
GRAPE KING BIO LTD	+1.28%	714M
ZHEJIANG NHU COMPANY LTD.	+5.54%	7.59B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+0.22%	5.93B
BYHEALTH CO., LTD	-8.57%	3.66B
THE SIMPLY GOOD FOODS COMPANY	-14.53%	3.38B
XIAMEN KINGDOMWAY GROUP COMPANY	-15.31%	1.16B
SIRIO PHARMA CO., LTD.	+12.72%	979M
HERBALIFE LTD.	-39.96%	922M
USANA HEALTH SCIENCES, INC.	-17.91%	861M
JAMIESON WELLNESS INC.	-16.70%	800M

Special Foods & Wellbeing Products